Targeted mouse complement inhibitor CR2-Crry protects against the development of atherosclerosis in mice

OBJECTIVE: Atherosclerosis is a chronic inflammatory and immune vascular disease, and clinical and experimental evidence has indicated an important role of complement activation products, including the terminal membrane attack complex (MAC), in atherogenesis. Here, we investigated whether complement...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Atherosclerosis
Main Authors: Liu, Fengming, Wu, Lin, Wu, Gongxiong, Wang, Chun, Zhang, Lining, Tomlinson, Stephen, Qin, Xuebin
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267679/
https://ncbi.nlm.nih.gov/pubmed/24685815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.atherosclerosis.2014.03.004
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki